Changes in serum protease and cytokine in patients with silicosis, tuberculosis, and lung cancer.
- Author:
Rongming MIAO
1
;
Bangmei DING
;
Dehong YOU
;
Qingjun YOU
;
Yingyi ZHANG
;
Zhonghua FANG
;
Feng GAO
;
Guiliang QIAN
;
Rong CAO
;
Qian XIA
;
Yong LI
Author Information
- Publication Type:Journal Article
- MeSH: Biomarkers; Cathepsin G; metabolism; Cytokines; blood; Endopeptidases; blood; Enzyme-Linked Immunosorbent Assay; Granzymes; metabolism; Humans; Interferon-beta; metabolism; Lung Neoplasms; enzymology; Silicosis; enzymology; Tuberculosis; enzymology
- From: Chinese Journal of Industrial Hygiene and Occupational Diseases 2015;33(8):598-600
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo investigate the changes in serum protease and cytokine in patients with silicosis, tuberculosis, and lung cancer.
METHODSSerum samples of patients with silicosis, tuberculosis, and lung cancer were collected. The variation trends of the expression of granzyme A, cathepsin G, apolipoprotein A, and interferon-β (IFN-β) were analyzed using enzyme-linked immunosorbent assay.
RESULTSThe concentration of apolipoprotein A of the silicosis group was 200 µg/ml, significantly higher than those of the tuberculosis and lung cancer groups (P < 0.05), and the lung cancer group had a significantly higher concentration of apolipoprotein A compared with the tuberculosis group (P < 0.05). The silicosis group had significantly higher expression of cathepsin G compared with the tuberculosis and lung cancer groups (P < 0.05), and the tuberculosis group and lung cancer group showed no significant difference in the concentration of cathepsin G (P > 0.05). The tuberculosis group had a significantly higher concentration of granzyme A than the silicosis and lung cancer groups (P < 0.05), and the silicosis group and lung cancer group had similar protein concentration trends (P > 0.05). The tuberculosis group and lung cancer group had significantly higher concentration of IFN-β compared with the silicosis group (P < 0.05), and the tuberculosis group and lung cancer group showed no significant difference in IFN-β concentration (P > 0.05).
CONCLUSIONThis study may offer diagnostic markers for the clinical diagnosis of silicosis, tuberculosis, and lung cancer, and could provide a basis for the research, as well as potential molecular targets for the diagnosis and treatment of these diseases.